Celyad Oncology SA (CYAD) Stock News

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement...

Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

MONT-SAINT-GUIBERT, Belgium, Aug. 24, 2023 (GLOBE NEWSWIRE) -- regulated information / inside information - Celyad Oncology SA (“Celyad” or the...

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

Celyad Oncology announces receipt of Nasdaq delisting notice

MONT-SAINT-GUIBERT, Belgium, May 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), is a biotechnology company...

12 Health Care Stocks Moving In Friday's Pre-Market Session

Mentions: OMI TBIO CANF SNGX ...

Celyad plans to delist from Nasdaq amid cash woes

Celyad Oncology (CYAD) is delisting its American Depositary Shares (ADSs) from Nasdaq. Read more here

Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq

MONT-SAINT-GUIBERT, Belgium, May 05, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

Celyad Oncology reports first quarter 2023 financial results and recent business highlights

Presentation of updated data on our multiplex shRNA platform, which allows targeting of up to four genes simultaneouslyPublication of results from the...

Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price

MONT-SAINT-GUIBERT, Belgium, April 24, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

12 Health Care Stocks Moving In Wednesday's Intraday Session

Mentions: IBIO BIOL MTNB BLCM ...

Celyad Oncology announces receipt of Nasdaq notice

MONT-SAINT-GUIBERT, Belgium, April 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

Celyad Oncology appoints Georges Rawadi as its new CEO

MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

Celyad Oncology reports full year 2022 financial results and recent business highlights

Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with one clear objective: help to overcome the current limitations...

Celyad Oncology to announce full year 2022 financial results and host conference call

MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning!

Mentions: JNCE STBX SWVL LYLT ...

Celyad stock slumps ~30% as board to put proposal to continue activities on vote

Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan...

Celyad Oncology announces non-cash impairment

MONT-SAINT-GUIBERT, Belgium, March 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...

Celyad Oncology SA - Letter to Shareholders

MONT-SAINT-GUIBERT, Belgium, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The following is a statement by Celyad Oncology: Dear Shareholder, 2022 has been a...